ID   SYAM_HUMAN              Reviewed;         985 AA.
AC   Q5JTZ9; A2RRN5; Q8N198; Q96D02; Q9ULF0;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 1.
DT   12-APR-2017, entry version 114.
DE   RecName: Full=Alanine--tRNA ligase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03133};
DE            EC=6.1.1.7 {ECO:0000255|HAMAP-Rule:MF_03133};
DE   AltName: Full=Alanyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_03133};
DE            Short=AlaRS {ECO:0000255|HAMAP-Rule:MF_03133};
DE   Flags: Precursor;
GN   Name=AARS2 {ECO:0000255|HAMAP-Rule:MF_03133};
GN   Synonyms=AARSL, KIAA1270;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-339.
RC   TISSUE=Brain;
RX   PubMed=10574462; DOI=10.1093/dnares/6.5.337;
RA   Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:337-345(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-339.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION.
RX   PubMed=15779907; DOI=10.1021/bi047527z;
RA   Bonnefond L., Fender A., Rudinger-Thirion J., Giege R., Florentz C.,
RA   Sissler M.;
RT   "Toward the full set of human mitochondrial aminoacyl-tRNA
RT   synthetases: characterization of AspRS and TyrRS.";
RL   Biochemistry 44:4805-4816(2005).
RN   [5]
RP   SUBCELLULAR LOCATION, AND VARIANTS COXPD8 ARG-155 AND TRP-592.
RX   PubMed=21549344; DOI=10.1016/j.ajhg.2011.04.006;
RA   Gotz A., Tyynismaa H., Euro L., Ellonen P., Hyotylainen T., Ojala T.,
RA   Hamalainen R.H., Tommiska J., Raivio T., Oresic M., Karikoski R.,
RA   Tammela O., Simola K.O., Paetau A., Tyni T., Suomalainen A.;
RT   "Exome sequencing identifies mitochondrial alanyl-tRNA synthetase
RT   mutations in infantile mitochondrial cardiomyopathy.";
RL   Am. J. Hum. Genet. 88:635-642(2011).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   INVOLVEMENT IN LKENP, VARIANTS LKENP CYS-50; LYS-405 AND ARG-965,
RP   VARIANTS VAL-77; PHE-131 DEL; CYS-199 AND MET-730, AND
RP   CHARACTERIZATION OF VARIANT LKENP CYS-50.
RX   PubMed=24808023; DOI=10.1212/WNL.0000000000000497;
RA   Dallabona C., Diodato D., Kevelam S.H., Haack T.B., Wong L.J.,
RA   Salomons G.S., Baruffini E., Melchionda L., Mariotti C., Strom T.M.,
RA   Meitinger T., Prokisch H., Chapman K., Colley A., Rocha H., Ounap K.,
RA   Schiffmann R., Salsano E., Savoiardo M., Hamilton E.M., Abbink T.E.,
RA   Wolf N.I., Ferrero I., Lamperti C., Zeviani M., Vanderver A.,
RA   Ghezzi D., van der Knaap M.S.;
RT   "Novel (ovario) leukodystrophy related to AARS2 mutations.";
RL   Neurology 82:2063-2071(2014).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Catalyzes the attachment of alanine to tRNA(Ala) in a
CC       two-step reaction: alanine is first activated by ATP to form Ala-
CC       AMP and then transferred to the acceptor end of tRNA(Ala). Also
CC       edits incorrectly charged tRNA(Ala) via its editing domain.
CC       {ECO:0000255|HAMAP-Rule:MF_03133}.
CC   -!- CATALYTIC ACTIVITY: ATP + L-alanine + tRNA(Ala) = AMP +
CC       diphosphate + L-alanyl-tRNA(Ala). {ECO:0000255|HAMAP-
CC       Rule:MF_03133}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03133};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000255|HAMAP-
CC       Rule:MF_03133};
CC   -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_03133}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000255|HAMAP-
CC       Rule:MF_03133, ECO:0000269|PubMed:21549344}.
CC   -!- DOMAIN: Consists of three domains; the N-terminal catalytic
CC       domain, the editing domain and the C-terminal C-Ala domain. The
CC       editing domain removes incorrectly charged amino acids, while the
CC       C-Ala domain, along with tRNA(Ala), serves as a bridge to
CC       cooperatively bring together the editing and aminoacylation
CC       centers thus stimulating deacylation of misacylated tRNAs.
CC       {ECO:0000255|HAMAP-Rule:MF_03133}.
CC   -!- DISEASE: Combined oxidative phosphorylation deficiency 8 (COXPD8)
CC       [MIM:614096]: A mitochondrial disease characterized by a lethal
CC       infantile hypertrophic cardiomyopathy, generalized muscle
CC       dysfunction and some neurologic involvement. The liver is not
CC       affected. {ECO:0000269|PubMed:21549344}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Leukoencephalopathy, progressive, with ovarian failure
CC       (LKENP) [MIM:615889]: An autosomal recessive neurodegenerative
CC       disorder characterized by childhood- to adulthood-onset of signs
CC       of neurologic deterioration consisting of ataxia, spasticity, and
CC       cognitive decline with features of frontal lobe dysfunction. Brain
CC       MRI shows leukoencephalopathy with striking involvement of deep
CC       white matter, and cerebellar atrophy. All female patients develop
CC       premature ovarian failure. {ECO:0000269|PubMed:24808023}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the class-II aminoacyl-tRNA synthetase
CC       family. {ECO:0000255|HAMAP-Rule:MF_03133}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA86584.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB033096; BAA86584.1; ALT_INIT; mRNA.
DR   EMBL; AL353588; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC013593; AAH13593.1; -; mRNA.
DR   EMBL; BC033169; AAH33169.1; -; mRNA.
DR   EMBL; BC131728; AAI31729.1; -; mRNA.
DR   CCDS; CCDS34464.1; -.
DR   RefSeq; NP_065796.1; NM_020745.3.
DR   UniGene; Hs.158381; -.
DR   ProteinModelPortal; Q5JTZ9; -.
DR   SMR; Q5JTZ9; -.
DR   BioGrid; 121569; 25.
DR   IntAct; Q5JTZ9; 6.
DR   MINT; MINT-8051598; -.
DR   STRING; 9606.ENSP00000244571; -.
DR   DrugBank; DB00160; L-Alanine.
DR   iPTMnet; Q5JTZ9; -.
DR   PhosphoSitePlus; Q5JTZ9; -.
DR   BioMuta; AARS2; -.
DR   DMDM; 74742244; -.
DR   EPD; Q5JTZ9; -.
DR   MaxQB; Q5JTZ9; -.
DR   PaxDb; Q5JTZ9; -.
DR   PeptideAtlas; Q5JTZ9; -.
DR   PRIDE; Q5JTZ9; -.
DR   TopDownProteomics; Q5JTZ9; -.
DR   Ensembl; ENST00000244571; ENSP00000244571; ENSG00000124608.
DR   GeneID; 57505; -.
DR   KEGG; hsa:57505; -.
DR   UCSC; uc010jza.2; human.
DR   CTD; 57505; -.
DR   DisGeNET; 57505; -.
DR   GeneCards; AARS2; -.
DR   HGNC; HGNC:21022; AARS2.
DR   HPA; HPA035636; -.
DR   HPA; HPA061396; -.
DR   MalaCards; AARS2; -.
DR   MIM; 612035; gene.
DR   MIM; 614096; phenotype.
DR   MIM; 615889; phenotype.
DR   neXtProt; NX_Q5JTZ9; -.
DR   OpenTargets; ENSG00000124608; -.
DR   Orphanet; 319504; Combined oxidative phosphorylation defect type 8.
DR   PharmGKB; PA162375129; -.
DR   eggNOG; KOG0188; Eukaryota.
DR   eggNOG; COG0013; LUCA.
DR   GeneTree; ENSGT00390000016019; -.
DR   HOGENOM; HOG000156964; -.
DR   HOVERGEN; HBG017874; -.
DR   InParanoid; Q5JTZ9; -.
DR   KO; K01872; -.
DR   OMA; CGGFILH; -.
DR   OrthoDB; EOG091G00Z9; -.
DR   PhylomeDB; Q5JTZ9; -.
DR   TreeFam; TF300737; -.
DR   BRENDA; 6.1.1.7; 2681.
DR   Reactome; R-HSA-379726; Mitochondrial tRNA aminoacylation.
DR   GeneWiki; AARS2; -.
DR   GenomeRNAi; 57505; -.
DR   PRO; PR:Q5JTZ9; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000124608; -.
DR   CleanEx; HS_AARS2; -.
DR   Genevisible; Q5JTZ9; HS.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0004813; F:alanine-tRNA ligase activity; IMP:BHF-UCL.
DR   GO; GO:0016597; F:amino acid binding; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000049; F:tRNA binding; IBA:GO_Central.
DR   GO; GO:0070143; P:mitochondrial alanyl-tRNA aminoacylation; IMP:BHF-UCL.
DR   GO; GO:0033108; P:mitochondrial respiratory chain complex assembly; IMP:BHF-UCL.
DR   GO; GO:0006400; P:tRNA modification; IBA:GO_Central.
DR   HAMAP; MF_00036_B; Ala_tRNA_synth_B; 1.
DR   InterPro; IPR002318; Ala-tRNA-lgiase_IIc.
DR   InterPro; IPR018162; Ala-tRNA-ligase_IIc_anticod-bd.
DR   InterPro; IPR018165; Ala-tRNA-synth_IIc_core.
DR   InterPro; IPR018164; Ala-tRNA-synth_IIc_N.
DR   InterPro; IPR023033; Ala_tRNA_ligase_euk/bac.
DR   InterPro; IPR018163; Thr/Ala-tRNA-synth_IIc_edit.
DR   InterPro; IPR009000; Transl_B-barrel.
DR   InterPro; IPR012947; tRNA_SAD.
DR   Pfam; PF01411; tRNA-synt_2c; 1.
DR   Pfam; PF07973; tRNA_SAD; 1.
DR   PRINTS; PR00980; TRNASYNTHALA.
DR   SMART; SM00863; tRNA_SAD; 1.
DR   SUPFAM; SSF101353; SSF101353; 1.
DR   SUPFAM; SSF50447; SSF50447; 1.
DR   SUPFAM; SSF55186; SSF55186; 1.
DR   TIGRFAMs; TIGR00344; alaS; 1.
DR   PROSITE; PS50860; AA_TRNA_LIGASE_II_ALA; 1.
PE   1: Evidence at protein level;
KW   Aminoacyl-tRNA synthetase; ATP-binding; Cardiomyopathy;
KW   Complete proteome; Disease mutation; Ligase; Metal-binding;
KW   Mitochondrion; Nucleotide-binding; Polymorphism;
KW   Premature ovarian failure; Protein biosynthesis; Reference proteome;
KW   RNA-binding; Transit peptide; tRNA-binding; Zinc.
FT   TRANSIT       1     23       Mitochondrion. {ECO:0000255|HAMAP-
FT                                Rule:MF_03133}.
FT   CHAIN        24    985       Alanine--tRNA ligase, mitochondrial.
FT                                /FTId=PRO_0000250725.
FT   METAL       632    632       Zinc. {ECO:0000255|HAMAP-Rule:MF_03133}.
FT   METAL       636    636       Zinc. {ECO:0000255|HAMAP-Rule:MF_03133}.
FT   METAL       749    749       Zinc. {ECO:0000255|HAMAP-Rule:MF_03133}.
FT   METAL       753    753       Zinc. {ECO:0000255|HAMAP-Rule:MF_03133}.
FT   VARIANT      50     50       F -> C (in LKENP; deleterious only under
FT                                stress conditions; dbSNP:rs587777590).
FT                                {ECO:0000269|PubMed:24808023}.
FT                                /FTId=VAR_071837.
FT   VARIANT      77     77       A -> V (found in patient with
FT                                leukoencephalopathy; unknown pathological
FT                                significance; dbSNP:rs375949891).
FT                                {ECO:0000269|PubMed:24808023}.
FT                                /FTId=VAR_071838.
FT   VARIANT     131    131       Missing (found in patient with
FT                                leukoencephalopathy; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:24808023}.
FT                                /FTId=VAR_071839.
FT   VARIANT     155    155       L -> R (in COXPD8; dbSNP:rs387907061).
FT                                {ECO:0000269|PubMed:21549344}.
FT                                /FTId=VAR_065956.
FT   VARIANT     199    199       R -> C (found in patient with
FT                                leukoencephalopathy; unknown pathological
FT                                significance; dbSNP:rs200105202).
FT                                {ECO:0000269|PubMed:24808023}.
FT                                /FTId=VAR_071840.
FT   VARIANT     339    339       I -> V (in dbSNP:rs324136).
FT                                {ECO:0000269|PubMed:10574462,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_027609.
FT   VARIANT     405    405       E -> K (in LKENP; dbSNP:rs587777592).
FT                                {ECO:0000269|PubMed:24808023}.
FT                                /FTId=VAR_071841.
FT   VARIANT     484    484       A -> D (in dbSNP:rs495294).
FT                                /FTId=VAR_027610.
FT   VARIANT     592    592       R -> W (in COXPD8; dbSNP:rs138119149).
FT                                {ECO:0000269|PubMed:21549344}.
FT                                /FTId=VAR_065957.
FT   VARIANT     730    730       V -> M (found in patient with
FT                                leukoencephalopathy; unknown pathological
FT                                significance; dbSNP:rs35623954).
FT                                {ECO:0000269|PubMed:24808023}.
FT                                /FTId=VAR_071842.
FT   VARIANT     850    850       M -> V (in dbSNP:rs35783144).
FT                                /FTId=VAR_057357.
FT   VARIANT     965    965       G -> R (in LKENP; dbSNP:rs543267101).
FT                                {ECO:0000269|PubMed:24808023}.
FT                                /FTId=VAR_071843.
SQ   SEQUENCE   985 AA;  107340 MW;  721368BD05474F86 CRC64;
     MAASVAAAAR RLRRAIRRSP AWRGLSHRPL SSEPPAAKAS AVRAAFLNFF RDRHGHRLVP
     SASVRPRGDP SLLFVNAGMN QFKPIFLGTV DPRSEMAGFR RVANSQKCVR AGGHHNDLED
     VGRDLSHHTF FEMLGNWAFG GEYFKEEACN MAWELLTQVY GIPEERLWIS YFDGDPKAGL
     DPDLETRDIW LSLGVPASRV LSFGPQENFW EMGDTGPCGP CTEIHYDLAG GVGAPQLVEL
     WNLVFMQHNR EADGSLQPLP QRHVDTGMGL ERLVAVLQGK HSTYDTDLFS PLLNAIQQGC
     RAPPYLGRVG VADEGRTDTA YRVVADHIRT LSVCISDGIF PGMSGPPLVL RRILRRAVRF
     SMEILKAPPG FLGSLVPVVV ETLGDAYPEL QRNSAQIANL VSEDEAAFLA SLERGRRIID
     RTLRTLGPSD MFPAEVAWSL SLCGDLGLPL DMVELMLEEK GVQLDSAGLE RLAQEEAQHR
     ARQAEPVQKQ GLWLDVHALG ELQRQGVPPT DDSPKYNYSL RPSGSYEFGT CEAQVLQLYT
     EDGTAVASVG KGQRCGLLLD RTNFYAEQGG QASDRGYLVR AGQEDVLFPV ARAQVCGGFI
     LHEAVAPECL RLGDQVQLHV DEAWRLGCMA KHTATHLLNW ALRQTLGPGT EQQGSHLNPE
     QLRLDVTTQT PLTPEQLRAV ENTVQEAVGQ DEAVYMEEVP LALTAQVPGL RSLDEVYPDP
     VRVVSVGVPV AHALDPASQA ALQTSVELCC GTHLLRTGAV GDLVIIGDRQ LSKGTTRLLA
     VTGEQAQQAR ELGQSLAQEV KAATERLSLG SRDVAEALRL SKDIGRLIEA VETAVMPQWQ
     RRELLATVKM LQRRANTAIR KLQMGQAAKK TQELLERHSK GPLIVDTVSA ESLSVLVKVV
     RQLCEQAPST SVLLLSPQPM GKVLCACQVA QGAMPTFTAE AWALAVCSHM GGKAWGSRVV
     AQGTGSTTDL EAALSIAQTY ALSQL
//
